semaglutide analogues Strictures of GLP-1 analogues: Native GLP-1, exenatide, liraglutide, Effects of GLP-1 analogs (liraglutide

Alexander Kokkinos Carel Le Roux To view or add a comment, sign in Tirzepatide: Redefining Outcomes in Diabetes & Obesity Care Clinical trials show tirzepatide, a dual GIP/GLP-1 receptor agonist, is delivering results beyond expectations: Up to 20.9% mean weight loss at 72 weeks (SURMOUNT-1, NEJM) 94% risk reduction in progression from prediabetes to type 2 diabetes over 3 years Superior HbA1c reduction and weight control vs leading GLP-1 therapies (SURPASS program) With manageable side effects and durable outcomes, tirzepatide is reshaping how we approach metabolic disease

Rare but serious risks include allergic reactions, thyroid cancer, and kidney issues

Find the right solution for ordering, patient care, and practice growth

One concern I hear from patients is whether moving from an injectable treatment to a tablet means going back to the beginning

These small steps can help you incorporate your injection into your life with less hassle